India · Delayed Price · Currency is INR Zydus Wellness Statistics
Total Valuation
Zydus Wellness has a market cap or net worth of INR 148.53 billion. The enterprise value is 177.59 billion.
| Market Cap | 148.53B |
| Enterprise Value | 177.59B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
| Current Share Class | 318.16M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 0.85% |
| Owned by Institutions (%) | 22.61% |
| Float | 93.45M |
Valuation Ratios
The trailing PE ratio is 60.43 and the forward PE ratio is 38.30.
| PE Ratio | 60.43 |
| Forward PE | 38.30 |
| PS Ratio | 2.98 |
| PB Ratio | 2.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 40.59 |
| P/OCF Ratio | 33.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.44, with an EV/FCF ratio of 48.48.
| EV / Earnings | 72.55 |
| EV / Sales | 3.56 |
| EV / EBITDA | 27.44 |
| EV / EBIT | 41.72 |
| EV / FCF | 48.48 |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.99 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 4.87 |
| Debt / FCF | 8.60 |
| Interest Coverage | 3.28 |
Financial Efficiency
Return on equity (ROE) is 4.24% and return on invested capital (ROIC) is 3.89%.
| Return on Equity (ROE) | 4.24% |
| Return on Assets (ROA) | 2.64% |
| Return on Invested Capital (ROIC) | 3.89% |
| Return on Capital Employed (ROCE) | 4.45% |
| Weighted Average Cost of Capital (WACC) | 3.83% |
| Revenue Per Employee | 29.75M |
| Profits Per Employee | 1.46M |
| Employee Count | 1,685 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, Zydus Wellness has paid 594.00 million in taxes.
| Income Tax | 594.00M |
| Effective Tax Rate | 19.44% |
Stock Price Statistics
The stock price has increased by +1.96% in the last 52 weeks. The beta is -0.06, so Zydus Wellness's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | +1.96% |
| 50-Day Moving Average | 508.28 |
| 200-Day Moving Average | 492.81 |
| Relative Strength Index (RSI) | 43.30 |
| Average Volume (20 Days) | 285,909 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zydus Wellness had revenue of INR 50.13 billion and earned 2.46 billion in profits. Earnings per share was 7.74.
| Revenue | 50.13B |
| Gross Profit | 31.87B |
| Operating Income | 4.28B |
| Pretax Income | 3.06B |
| Net Income | 2.46B |
| EBITDA | 6.48B |
| EBIT | 4.28B |
| Earnings Per Share (EPS) | 7.74 |
Balance Sheet
The company has 2.62 billion in cash and 31.67 billion in debt, with a net cash position of -29.05 billion.
| Cash & Cash Equivalents | 2.62B |
| Total Debt | 31.67B |
| Net Cash | -29.05B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 59.08B |
| Book Value Per Share | 185.34 |
| Working Capital | 7.32B |
Cash Flow
In the last 12 months, operating cash flow was 4.45 billion and capital expenditures -771.00 million, giving a free cash flow of 3.68 billion.
| Operating Cash Flow | 4.45B |
| Capital Expenditures | -771.00M |
| Depreciation & Amortization | 2.20B |
| Net Borrowing | -539.00M |
| Free Cash Flow | 3.68B |
| FCF Per Share | n/a |
Margins
Gross margin is 63.56%, with operating and profit margins of 8.54% and 4.91%.
| Gross Margin | 63.56% |
| Operating Margin | 8.54% |
| Pretax Margin | 6.09% |
| Profit Margin | 4.91% |
| EBITDA Margin | 12.93% |
| EBIT Margin | 8.54% |
| FCF Margin | 7.35% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 15.56% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.31% |
| Earnings Yield | 1.65% |
| FCF Yield | 2.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Zydus Wellness is 582.63, which is 24.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 582.63 |
| Price Target Difference | 24.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 20.31% |
| EPS Growth Forecast (3Y) | 41.27% |
Stock Splits
The last stock split was on September 18, 2025. It was a forward split with a ratio of 5.
| Last Split Date | Sep 18, 2025 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |